IFN-γ and IL-10 are two cytokines involved in the regulation of T cells activity, playing an opposite role, so we focused on their expression on PBMCs to evaluate a correlation with tumor response in advanced melanoma patients treated with anti-PD-1 drugs. This evidence concerns the gene IL10 and melanoma.